Evidence map›Paper›PMID 37097384›Full record

ArticleClinical and experimental medicine2023

Interleukin-6

Salvatore Rotundo, Massimo Borelli, Vincenzo Scaglione, Rosaria Lionello, Flavia Biamonte, Vincenzo Olivadese, Angela Quirino, Helen Linda Morrone, Giovanni Matera, Francesco Saverio Costanzo and 4 more

Abstract read
In one paragraph

Article in Clinical and experimental medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Salvatore RotundoDepartment of Medical and Surgical Sciences, University "Magna Graecia", Catanzaro, Italy. srotundo91@gmail.com.
Massimo BorelliUMG School of PhD Programmes, University "Magna Graecia", Catanzaro, Italy.
Vincenzo ScaglioneDepartment of Medical and Surgical Sciences, University "Magna Graecia", Catanzaro, Italy.
Rosaria LionelloDepartment of Medical and Surgical Sciences, University "Magna Graecia", Catanzaro, Italy.
Flavia BiamonteDepartment of Clinical and Experimental Medicine, University "Magna Graecia", Catanzaro, Italy.
Vincenzo OlivadeseDepartment of Medical and Surgical Sciences, University "Magna Graecia", Catanzaro, Italy.
Angela QuirinoDepartment of Health Sciences, University "Magna Graecia", Catanzaro, Italy.
Helen Linda MorroneDepartment of Medical and Surgical Sciences, University "Magna Graecia", Catanzaro, Italy.
Giovanni MateraDepartment of Health Sciences, University "Magna Graecia", Catanzaro, Italy.
Francesco Saverio CostanzoDepartment of Clinical and Experimental Medicine, University "Magna Graecia", Catanzaro, Italy.
Alessandro RussoDepartment of Medical and Surgical Sciences, University "Magna Graecia", Catanzaro, Italy.
Enrico Maria TrecarichiDepartment of Medical and Surgical Sciences, University "Magna Graecia", Catanzaro, Italy.
Carlo TortiDepartment of Medical and Surgical Sciences, University "Magna Graecia", Catanzaro, Italy.
IDTM UMG COVID-19 Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In a convenience sample of 93 patients treated with monoclonal antibodies (moAbs) against SARS-CoV-2, the interleukin-6

Indexed as

COVID-19Antibodies, MonoclonalDisease ProgressionHumansInterleukin-6LymphocytesSARS-CoV-2Antibodies, MonoclonalInterleukin-6COVID-19InterleukinLymphocytesMonoclonal antibodiesSARS-CoV-2

Identifiers

PMID37097384
PMCPMC10127195

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.